Tandem Diabetes Care Announces Second Quarter 2019 Financial Results and Updated 2019 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Trump says Canada's Bombardier must build jets in US or lose market access
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- European shares subdued as surging crude sharpens focus on ECB rate path
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Tandem Diabetes (TNDM) Tops Q2 EPS by 22c, Revenues Beat; Offers FY19 Sales Outlook Above Consensus
August 1, 2019 5:08 PM EDTTandem Diabetes (NASDAQ: TNDM) reported Q2 EPS of ($0.03), $0.22 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $93.26 million versus the consensus estimate of $70.03 million.
In comparing the second quarter of 2019 to the same period of 2018:
Worldwide pump shipments increased 290 percent to 21,258 pumps from 5,447 pumpsSales increased 173 percent to $93.3 million from $34.1 millionOperating margin improved to negative 2 percent from negative 41 percentAdjusted EBITDA(1) improved to 13 percent of sales from negative 29 percent of salesWe shipped more pumps in... More
